Fighting back: optimising treatment for COVID-19

P189 Use of angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers in COVID-19 infection does not adversely affect clinical outcomes including need for non-invasive and invasive ventilation

Pub Date : 2021-11-01 DOI: 10.1136/thorax-2021-btsabstracts.298 A. Amrapala, M. Win, A. Ainley

P190 The impact of drug therapies on COVID-19 mortality in a UK tertiary centre

Pub Date : 2021-11-01 DOI: 10.1136/thorax-2021-btsabstracts.299 T. Kurmoo, M. Mayisha Ahmad, R. Wang, N. Chaudhuri

P188 Tick tock...where and when can we give toc? Review of COVID-19 patients receiving tocilizumab in a non critical care setting

Pub Date : 2021-11-01 DOI: 10.1136/thorax-2021-btsabstracts.297 K. Aiken, M. Wilson, E. Keelan